Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With CKD and Type 2 Diabetes

被引：0
|
作者：
Fu, Edouard [1 ,2 ]
D'Andrea, Elvira [1 ,2 ]
Wexler, Deborah J. [2 ,3 ]
Patorno, Elisabetta [1 ,2 ]
Paik, Julie M. [1 ,2 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA USA
[2] Harvard Med Sch, Boston, MA USA
[3] Massachusetts Gen Hosp, Boston, MA USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
SA-PO260
引用
收藏
页码：673 / 673
页数：1
相关论文
共 50 条
  • [21] Comparison of Efficacy and Safety Profile of Sodium-Glucose Cotransporter-2 Inhibitors as Add-On Therapy in Patients With Type 2 Diabetes
    Hussain, Mazhar
    Elahi, Asim
    Iqbal, Javed
    Ghafoor, Muhammad
    Rehman, Habib
    Akhtar, Shoaib
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (04)
  • [22] Hypothetical intervention of sodium-glucose cotransporter-2 inhibitors on renal outcome in type 2 diabetes
    Takeuchi, Masato
    Kawakami, Koji
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 131 - 132
  • [23] Sodium-glucose cotransporter-2 inhibitors and genital and urinary tract infections in type 2 diabetes
    Arakaki, Richard F.
    POSTGRADUATE MEDICINE, 2016, 128 (04) : 409 - 417
  • [24] Sodium-Glucose Cotransporter 2 Inhibitors in Older Patients with CKD
    Bakker, Wisanne M.
    Gansevoort, Ron T.
    Yang, Changyuan
    Chertow, Glenn M.
    Heerspink, Hiddo J. L.
    Vart, Priya
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10): : 1446 - 1449
  • [25] Effects of sodium-glucose cotransporter-2 inhibitors on the cardiovascular and renal complications of type 2 diabetes
    Chilton, Robert J.
    DIABETES OBESITY & METABOLISM, 2020, 22 (01): : 16 - 29
  • [26] Obesity as a modifier of the cardiovascular effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes
    Suissa, Karine
    Schneeweiss, Sebastian
    Douros, Antonios
    Yin, Hui
    Patorno, Elisabetta
    Azoulay, Laurent
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 192
  • [27] Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Events, Stroke, and Mortality in Patients with Type 2 Diabetes
    Kawada, Tomoyuki
    CARDIOVASCULAR DRUGS AND THERAPY, 2023, 37 (04) : 619 - 620
  • [28] Sodium-glucose cotransporter-2 inhibitors in diabetes and inflammatory skin diseases
    Shen, Chin-Hsuan
    Yang, Yi-Sun
    Lee, Irene Tai-Lin
    Chiang, Meng-Han
    Chen, Steven T.
    Ma, Kevin Sheng-Kai
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 (03) : 467 - 468
  • [29] Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Events, Stroke, and Mortality in Patients with Type 2 Diabetes
    Tomoyuki Kawada
    Cardiovascular Drugs and Therapy, 2023, 37 : 619 - 620
  • [30] Should sodium-glucose cotransporter-2 inhibitors be first-line treatment for patients with type 2 diabetes?
    van Walraven, Carl
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2020, 192 (14) : E375 - E376
12345